Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00407303
Status:
COMPLETED
Last Update Posted:
2016-07-21
First Post:
2006-12-01
Brief Title:
Safety and Efficacy of Obatoclax Mesylate GX15-070MS in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma MCL
Sponsor:
Gemin X
Organization:
Teva Branded Pharmaceutical Products RD Inc
Organization Data
Organization:
Teva Branded Pharmaceutical Products RD Inc
Class:
INDUSTRY
Study ID:
GEM012
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gemin X
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None